Clin2
NCT07267299Possibly a fitNot yet recruiting

Switching from Restasis to a new dry eye drop, TRYPTYR

Dry EyeEye DiseasesChronic Dry Eye

Treatments studied

Part of Eyes & vision clinical trials.

This study tests a new dry eye drop called TRYPTYR for people who have been using Restasis but are not satisfied with it. If you qualify, you would stop Restasis and try TRYPTYR to see if it works better for your symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
100 people
Ages
18 years to 100 years
Study type
Interventional

Who can take part

  • You are at least 18 years old.
  • You have had dry eye disease for at least 6 months.
  • You are currently using Restasis and have been taking it for at least 1 month.
  • You are not happy with how well Restasis works and plan to stop using it.
  • You are willing to stop wearing contact lenses during the study.
  • You do not have a condition like Sjögren's syndrome or have had eye surgery in the past year.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07266948Recruiting· Phase 4
How TRYPTYR eye drops affect dry eye symptoms and daily life

This study tests a new eye drop called TRYPTYR to see if it can improve quality of life and daily tasks for people with dry eye disease who are unhappy with their current treatment, Restasis. Participants will stop using Restasis and switch to TRYPTYR for about 4 weeks.

Pittsburg, Kansas
NCT07267481Not yet recruiting· Phase 4
Switching from Xiidra to a new dry eye drop

This study tests if switching from Xiidra to another dry eye drop (TRYPTYR) works better for people with dry eye disease. You may qualify if Xiidra isn't helping enough and you've been using it for at least a month.

NCT07625124Not yet recruiting· Phase 2
Testing a new eye drop for dry eye disease

This study tests whether RCI001, a new eye drop treatment, can help people with dry eye disease. If you've had dry eye symptoms for at least 6 months and are interested in trying a new treatment, this trial may be for you.

NCT06379685Not yet recruiting· Phase 1
Testing new eye drops for safety and comfort

This study tests a new eye drop (PRO-190) against a common artificial tear (Systane Ultra) to see how safe and comfortable it is. Healthy volunteers will use the drops and be monitored for any side effects or changes in their eyes.

NCT07277257Recruiting· Phase 4
New dry eye treatment for people with Sjögren's syndrome

This study tests a new treatment for dry eye disease caused by Sjögren's syndrome. It may help people who still have dry eye symptoms even when using artificial tears.

Venice, Florida
NCT07732010Recruiting· Phase 4
Tryptophan for dry eye disease

This trial tests whether a dietary supplement called TRYPTYR can improve dry eye symptoms. You may qualify if you have moderate dry eye with certain signs, like short tear breakup time and staining on your eye surface.

New York, New York

Hear when a new Dry Eye trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.